MB
Microbot Medical Inc.
MBOT · NASDAQ
$1.36 -4.56% (-$0.06)
1M -8.72%
Market Cap $66.5M
P/E Ratio -
Div. Yield -
ROE 21.87%
Bulios Fair Price
$1.49
9.6% upside
Current Price
$1.36
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MBOT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 192.29x
P/B 0.97x
P/E N/A
Growth
100 /100
Growing Book val. growth 119.94%
EPS growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 185.26%
Net margin 4,722.25%
FCF margin 5,181.79%
Quality
0 /100
Poor ROIC 26.51%
ROE 21.87%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 18.56x
Int. coverage N/A
Stability
74 /100
Stable Beta 1.03x
EPS volatility 15.03%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MBOT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Harel Gadot
Employees
43
Headquarters
Hingham
Upcoming events
11 NOV
Earnings
Upcoming earnings report